Conquering the number one killer of Minnesotans is no easy task.
Studies in genetics, cell and vaccine therapies, immunology, and blood and marrow transplantation combine with the University's specialized cell processing facilities to provide innovative treatments to conquer this killer.
Home to the Masonic Cancer Center – the Twin Cities’ only National Cancer Institute-designated comprehensive cancer center – we have the depth and breadth in research and care to reduce the toll of this deadly disease.
Nelson Rhodus
Nelson Rhodus studies how DNA in cells in saliva may predict if a person is at risk for developing oral cancer in order to one day eliminate invasive biopsies.
From the AHC
U joins cancer genome project
The Cancer Genome Atlas is a nationwide effort to understand how errors in DNA cause cancer.
-
Searching for a more effective approach to ovarian cancer treatment
10/14/11
Could gene biomarkers predict a patient's response to ovarian cancer therapy?
-
Institute gets 5-year grant to study breast cancer
09/09/11
Dr. Margot Cleary was awarded a $1.5 million grant to research a diabetes drug's potential anti-cancer effects.
-
U of M researcher awarded $3.5 million to study rare tumor
08/29/11
Pediatric cancer expert Jenny Poynter is looking into pediatric germ cell tumors.
